Clinical trial
Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
NCT00279734 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00279734 |
|---|---|
| Title | Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers |
| Official title | An Exploratory Study to Evaluate the Effect of Abatacept (BMS-188667) on the Antibody Response Following Tetanus Toxoid and 23-Valent Pneumococcal Vaccinations in Healthy Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Tetanus + pnemococcal vaccines alone, Abatacept + vaccines, Abatacept + Vaccines |
| Enrollment | 80 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Jan 20, 2006 |
| Last update posted | Apr 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: